| Bid | 21.86 |
| Market Cap | 4.63B |
| Revenue (ttm) | - |
| Net Income (ttm) | - |
| EPS (ttm) | -1.58 |
| PE Ratio (ttm) | -14.08 |
| Forward PE | n/a |
| Analyst | Strong Buy |
| Ask | 22.99 |
| Volume | 1,162,127 |
| Avg. Volume (20D) | 1,331,409 |
| Open | 21.98 |
| Previous Close | 21.81 |
| Day's Range | 21.86 - 22.53 |
| 52-Week Range | 7.91 - 22.91 |
| Beta | undefined |
About CLBT
Cellebrite DI Ltd. develops solutions for legally sanctioned investigations. Its DI platform allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations and solutions are used in a various case, including child exploitation, homicide, anti-terror, border control, sexual crimes, human trafficking, corporate security, intellectual property theft, and civil li...
Analyst Forecast
According to 8 analyst ratings, the average rating for CLBT stock is "Strong Buy." The 12-month stock price forecast is $21, which is a decrease of -5.62% from the latest price.
Next Earnings Release
Analysts project revenue of $107.15M, reflecting a 15.20% YoY growth and earnings per share of 0.1, making a -9.09% decrease YoY.
2 months ago · seekingalpha.com
Cellebrite DI: Long-Term Growth Looks Positive, But Valuation IncreasedI previously rated Cellebrite DI a 'strong buy' due to its growth potential and attractive valuation. Since my recommendation, Cellebrite has outperformed, with the stock rising 160% compared to the S...
